AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01569919 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin B12
Description: 1000μg intramuscular, Day 2 of weeks 3 and 12
Study NCT01569919 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Folic Acid
Description: 400μg oral daily from Day 2 of week 3 to Day 2 of week 16
Study NCT01569919 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 4mg BD, Days 2-6 of weeks 4, 7, 10, 13
Study NCT05380869 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Point-of-care Test
Description: to test Point-of-care procalcitonin in suspected pneumonia
Study NCT01826695 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurodynamic technique group
Description: Neurodynamic techniques are used in order to move most of the nerves between the neck and hand, including the median nerve, radial and ulnar, brachial plexus, spinal nerves and cervical nerve roots.~The patient is placed supine position. The treatment will be carry out 3 times per week during 8 weeks.
Study NCT01826695 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: Women in this group realized standard treatment in the Fibromyalgia Association without neurodynamic techniques.
Study NCT01957319 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Silybin 94 mg + vitamin E 90 mg + phospholipids 194 mg
Study NCT01957319 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sugar pill
Study NCT03608618 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MCY-M11
Description: Intraperitoneal administration
Study NCT03608618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous administration for preconditioning
Study NCT03134950 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ADAPT
Description: Aim to Decrease Anxiety and Pain Treatment is a tailored CBT ranging from 4 sessions (pain-focused) to 6 sessions (blend of pain and anxiety coping strategies depending on the needs of the individual patients. The first 2 sessions will be in person with a trained psychologist and the following 2-4 sessions will be web-based. Each web-based session will be followed by phone support.
Study NCT00668655 — intervention group
Intervention type: DRUG
Intervention: Metronidazole Gel
Description: Topical, Once daily for 2 weeks
Study NCT02811536 — intervention group
Intervention type: DEVICE
Intervention: optical coherence tomography angiography
Description: Imaging with optical coherence tomography angiography
Study NCT03706534 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Image review with CADe
Description: This software is a computer-aided detection (CADe) software application, designed to assist radiologist to analyze breast ultrasound images. S-Detect automatically segments and classifies shape, orientation, margin, lesion boundary, echo pattern, and posterior feature characteristics of user-selected region of interest. The device uses deep learning methods to perform tissue segmentation and classification of images.
Study NCT03706534 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound Image review with CADe
Description: This software is a computer-aided detection (CADe) software application, designed to assist radiologist to analyze breast ultrasound images. S-Detect automatically segments and classifies shape, orientation, margin, lesion boundary, echo pattern, and posterior feature characteristics of user-selected region of interest. The device uses deep learning methods to perform tissue segmentation and classification of images.
Study NCT03706534 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Image review with CADx
Description: This software is also a computer-assisted diagnostic(CADx) software application, designed to assist a medical doctor in determining diagnosis by presenting whether a lesion is malignant in a breast ultrasound image obtained from an ultrasound imaging device.
Study NCT03706534 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound Image review with CADx
Description: This software is also a computer-assisted diagnostic(CADx) software application, designed to assist a medical doctor in determining diagnosis by presenting whether a lesion is malignant in a breast ultrasound image obtained from an ultrasound imaging device.
Study NCT03706534 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Image manual review
Description: The images will be reviewed by the radiologists using BIRADS scheme without any assistance of artificial assistance. This review will be done off-line using a separate program in entirely manual mode. During this review, BIRADS descriptor choices by each radiologist and the time it takes for the radiologist to make such decision will be stored.
Study NCT03706534 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound Image manual review
Description: The images will be reviewed by the radiologists using BIRADS scheme without any assistance of artificial assistance. This review will be done off-line using a separate program in entirely manual mode. During this review, BIRADS descriptor choices by each radiologist and the time it takes for the radiologist to make such decision will be stored.
Study NCT03706534 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Suspicious lesions found on breast ultrasound are then followed either by ultrasound guided biopsy or ultrasound imaging every 6 months for two years. For those who undergo biopsy, ultrasound provides images which are used to localize the lesion and guide the placement of the biopsy needle. The sample is sent to pathology for diagnosis, while the ultrasound guidance images are stored. For those who have imaging follow-up, ultrasound images of the breast mass are obtained, digitally stored and interpreted by the radiologist typically using BIRADS scheme.
Study NCT03706534 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Suspicious lesions found on breast ultrasound are then followed either by ultrasound guided biopsy or ultrasound imaging every 6 months for two years. For those who undergo biopsy, ultrasound provides images which are used to localize the lesion and guide the placement of the biopsy needle. The sample is sent to pathology for diagnosis, while the ultrasound guidance images are stored. For those who have imaging follow-up, ultrasound images of the breast mass are obtained, digitally stored and interpreted by the radiologist typically using BIRADS scheme.
Study NCT01044381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luliconazole Solution, 10%
Description: 28 days of daily application
Study NCT00074412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nevirapine
Description: 10 mg/ml oral suspension taken once daily up to 6 months of age. Dosage will increase throughout study.
Study NCT00074412 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nevirapine placebo
Description: Oral suspension taken once daily up to 6 months of age
Study NCT04310215 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CARTISTEM®
Description: \*Stratified randomization by lesion size below 1.5㎠ or more than 1.5㎠~1. Procedure: Microfracture~2. Biological: CARTISTEM®(Human Umbilical Cord Blood-derived Mesenchymal Stem Cell product)
Study NCT04310215 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Microfracture
Description: \*Stratified randomization by lesion size below 1.5㎠ or more than 1.5㎠~1. Procedure: Microfracture
Study NCT00382980 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide
Description: Adjuvant administered with A/H5N1 vaccine dosages 7.5 mcg and 15 mcg.
Study NCT00382980 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated Vero cell based whole virus influenza A/H5N1
Description: Inactivated Vero cell-grown, whole virus, influenza A/H5N1 vaccine at dosages 7.5 mcg and 15 mcg of hemagglutinin (HA) per 0.5 mL, each dosage with and without aluminum hydroxide adjuvant; 45 mcg HA/0.5 mL without adjuvant.
Study NCT00382980 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline injected into the deltoid muscle. 2 identical dosages will be given approximately 28 days apart.
Study NCT03505138 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group intervention
Description: GROUP 1 (telematic group):~These patients will have a tablet connected via internet (Telefónica-e-Health). They have to measure their lung function, temperature, pulse oxymetry and symtoms questionnaire every week. The device (tablet) asks them about possible COPD exacerbation. If the patient has an exacerbation, the device offers them a treatment for this exacerbation and it begins a following of this exacerbation until resolution, every day.~The pneumologists will receive an alert in other tablet when the patients have an exacerbation or worsening of their diseases.~The period of monitoring is 1 year.
Study NCT03505138 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: health care system
Description: GROUP 2 (conventional group or control group) Patients with a COPD exacerbation can go to their family physicians or emergency services and these physicians will establish a treatment and a monitoring of these exacerbation (conventional group).~The period of monitoring is 1 year.
Study NCT04821973 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Radius PPG Tetherless Pulse Oximetry (Masimo)
Description: continuous monitoring by a portable, wireless and stand-alone device
Study NCT01002768 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin degludec
Description: Day 1-4: Once daily subcutaneous (under the skin) injection similar to 80% of individual basal insulin requirement. Day 5: Three times the individual basal insulin requirement.
Study NCT01002768 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin glargine
Description: Day 1-4: Once daily subcutaneous (under the skin) injection similar to 80% of individual basal insulin requirement. Day 5: Three times the individual basal insulin requirement.
Study NCT03907046 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Apixaban
Description: Apixaban is an oral anticoagulant of the Factor Xa inhibitor class.
Study NCT03907046 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Aspirin
Description: Aspirin is an oral antiplatelet drug.
Study NCT04542031 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaire
Description: Questionnaire to be completed at 6 and 12 months
Study NCT01385189 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 10 μg Na-GST-1/Alhydrogel
Description: 3 doses 10 μg Na-GST-1/Alhydrogel administered at 56 day intervals
Study NCT01385189 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 30 μg Na-GST-1/Alhydrogel
Description: 3 doses 30 μg Na-GST-1/Alhydrogel administered at 56 day intervals
Study NCT01385189 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 100 μg Na-GST-1/Alhydrogel
Description: 3 doses 100 μg Na-GST-1/Alhydrogel administered at 56 day intervals
Study NCT01385189 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 10 μg Na-GST-1/Alhydrogel/GLA-AF (1 μg)
Description: 3 doses 10 μg Na-GST-1/Alhydrogel/GLA-AF (1 μg) administered at 56 day intervals
Study NCT01385189 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 30 μg Na-GST-1/Alhydrogel/GLA-AF (1 μg)
Description: 3 doses of 30 μg Na-GST-1/Alhydrogel/GLA-AF (1 μg) administered at 56 day intervals
Study NCT01385189 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 30 μg Na-GST-1/Alhydrogel/GLA-AF (5 μg)
Description: 3 doses 30 μg Na-GST-1/Alhydrogel/GLA-AF (5 μg) administered at 56 day intervals
Study NCT01385189 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 100 μg Na-GST-1/Alhydrogel/GLA-AF (5 μg)
Description: 3 doses 100 μg Na-GST-1/Alhydrogel/GLA-AF (5 μg) administered at 56 day intervals
Study NCT02842684 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TraumaCad software
Description: restitution of anatomical- radiological parameters after total hip arthroplasty with TraumaCad , conventional planning systems and without planning.
Study NCT01615263 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lung isolation device
Description: Lung isolation for one-lung ventilation with a left double lumen tube
Study NCT01615263 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lung isolation device
Description: Lung isolation for one-lung ventilation with a bronchial blocker inserted through a 8.0 mm simple lumen endotracheal tube
Study NCT03176355 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Canaliculo- Dacryocystorhinostomy
Description: Bypass lacrimal passage obstruction by opening a shunt between the lacrimal sac and the nasal mucosa
Study NCT00594113 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Touch 2 Screen
Description: Multi-media presentation and survey to increase screening for colorectal cancer. Content of this presentation is based on the concept of implementation intentions, an advanced planning model taken from the Theory of Planned Behavior
Study NCT00594113 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Touch screen intervention
Description: Touch screen intervention
Study NCT03320096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microfocused ultrasound with visualization
Description: Subjects will receive 2 treatments (day 1 and day 30), each at a 3.0mm depth and 0.30 Joule of energy. Treatment will be delivered in a 3\*4 grid, 12 treatment squares, delivering 60 lines of treatment per square, i.e., 720 lines per axilla in each treatment (1440 lines total per treatment.)
Study NCT03710590 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ECIG Lab Session 15 watts, 10 mg nicotine
Description: During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
Study NCT03710590 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ECIG Lab Session 15 watts, 15 mg nicotine
Description: During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.).
Study NCT03710590 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ECIG Lab Session 15 watts, 30 mg nicotine
Description: During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
Study NCT03710590 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ECIG Lab Session 30 watts, 10 mg nicotine
Description: During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
Study NCT03710590 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ECIG Lab Session 30 watts, 15 mg nicotine
Description: During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
Study NCT03710590 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ECIG Lab Session 30 watts, 30 mg nicotine
Description: During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
Study NCT01865929 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robotic hysterectomy
Description: Minimally invasive hysterectomy for benign disorders. Comparing robotic hysterectomy with vaginal hysterectomy and traditional laparoscopic hysterectomy
Study NCT01865929 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal or laparoscopic hysterectomy
Description: Benign hysterectomy performed by traditional minimal invasive procedures.
Study NCT04821973 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: usual monitoring
Description: usual nurse respiratory monitoring
Study NCT02847208 — intervention group
Intervention type: OTHER
Intervention: self-report written questionnaire
Description: The questionnaire was filled-in by the patients in presence of a clinical nurse. The gynaecological healthcare options and contraceptive choices were recorded. All following questions were closed-ended (answer yes/no): use of contraception; use of contraceptive pill; use of contraceptive implant; use of intrauterine device; use of tubal sterilization; use of mechanical contraception; use of other type of contraception; previous delivery (term pregnancy); gynaecological follow-up; previous Pap smear. In case of a positive answer to one of these questions, more details were requested (depending on the situation: name of the contraception, date of delivery, frequency of the gynaecological follow-up, date of the last pap smear). An internal validation of the questionnaire was performed on a subgroup of patients.
Study NCT03319095 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intravaginal Electrical Nerve Stimulation
Description: The Intervention group will receive Intravaginal Electrical Nerve Stimulation using Quark® Dualpex equipment, once per week during 8 weeks. The selected current will be biphasic, and the stimulation parameters will be: 50 Hz frequency, pulse width of 200 microseconds, contraction time (Ton) of 5 seconds, relaxation time (Toff) of 10 seconds, intensity of current defined according to the sensitivity (tolerance) of the patient, and total stimulation time of 20 minutes once a week delivered by an experienced Physiotherapist. In the last 10 minutes of each electrical nerve stimulation session women will be requested to perform voluntary PFM contractions along with the contractions induced by the electrical stimulation. Women will not be instructed to perform any aditional exercise or therapy at home.
Study NCT02531594 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SBIRT
Description: The Social Worker will provide caregivers with the brief (10-15 minute) Advise, Assess, Assist intervention based on the Clinical Practice Guidelines, and tailored on levels of motivation to quit and tobacco dependence. Patients in this group will receive Nicotine Replacement Therapy vouchers, immediate connection to cessation resources, and intervention materials.
Study NCT02531594 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: HHC
Description: The Social Worker will provide caregivers with the brief (10-15 minute) Lets Go! 5-2-1-0 intervention which is a child obesity prevention program. Patients in this group will receive motivational interviewing in regards to helping children and families eat healthy and be active. This group will receive water bottle vouchers, immediate connection to 5-2-1-0 resources, and intervention materials.
Study NCT01042535 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: adenovirus-p53 transduced dendritic cell (DC) vaccine
Description: Given intradermally (ID)
Study NCT01042535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1-methyl-d-tryptophan
Description: Given orally (PO)
Study NCT01042535 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory biomarker analysis
Description: Correlative studies
Study NCT03919448 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Single-dose infusion
Study NCT02994628 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Water
Description: Water only without carbohydrate
Study NCT02994628 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mini banana
Description: Ingest mini banana containing higher phenolics and carbohydrate concentration
Study NCT02994628 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cavendish banana
Description: Ingest Cavendish banana (common banana)
Study NCT02994628 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 6% sugar beverage
Description: Ingest 6% sugar beverage containing same glucose and fructose profile as banana
Study NCT01524172 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga Based Psychotherapy Group
Description: YBPG promotes self-regulation (attention span and physical and verbal expression/outbursts); self-soothing (breathing and movement techniques that physiologically calm when the child encounters stress or reminders of trauma); competency (successful social interaction, appropriate expression of needs and feelings, healthy coping with stress or crisis); self-awareness (of thoughts and feelings by first increasing awareness of the body and its sensations through yoga); self-esteem (positive self-regard, increase accomplishments and awareness that all individuals have different abilities); and safety and personal boundaries (establishing personal boundaries and respecting others' personal boundaries, differentiate safe and unsafe behaviors and situations).
Study NCT01524172 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Mental Health Treatment
Description: Trauma and evidence informed therapy
Study NCT03813745 — intervention group
Intervention type: OTHER
Intervention: early denudation
Description: COCs will be denudated in 30 min after oocyte retrieval
Study NCT03813745 — intervention group
Intervention type: OTHER
Intervention: late denudation
Description: COCs will be denudated 2 hr after oocyte retrieval
Study NCT00696462 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: forced-air warming
Description: forced-air warming device
Study NCT02775760 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiovascular endurance
Description: Physical exercise at the Boston University Fitness and Recreation Center
Study NCT02775760 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Strength, balance, and flexibility
Description: Physical exercise at the Boston University Fitness and Recreation Center